Reported purpose & perceived effectiveness
- Can't tell
Before taking this medication, tell your doctor if you have
You may not be able to take chloroquine, or you may require a dosage adjustment or special monitoring during your therapy if you have any of the conditions listed above.
It is not known whether chloroquine will be harmful to an unborn baby. Do not take chloroquine without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known how chloroquine will affect a nursing infant. Do not take chloroquine without first talking to your doctor if you are breast-feeding a baby.
Use caution when driving or performing other hazardous activities until you know how this medication affects you. Chloroquine may cause visual disturbances such as blurred vision, misty vision, and difficulty focusing. Report any vision or hearing changes to your doctor.
Seek emergency medical attention if an overdose is suspected.
Symptoms of a chloroquine overdose include headache, drowsiness, nausea, vomiting, visual changes, seizures, difficulty breathing, and unconsciousness.
Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and only take the next regularly scheduled dose. Do not take a double dose of this medication.
Stop taking chloroquine and seek emergency medical attention if you experience an allergic reaction (flushing; swelling of the lips, tongue, or face; difficulty breathing; closing of the throat; vision problems; rash; itching; or fever).
Other, less serious side effects may be more likely to occur. Continue to take chloroquine and talk to your doctor if you experience
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.
Cimetidine (Tagamet, Tagamet HB) may increase the effects of chloroquine, which could lead to toxicity. Do not take cimetidine without first talking to your doctor.
Kaolin and magnesium trisilicate may decrease the effects of chloroquine. These ingredients can be found in products such as Kaopectate Advanced Formula, Parepectolin, K-Pek, K-C, Kaodene Non-Narcotic, Kao-Spen, Gaviscon, and others.
Drugs other than those listed here may also interact with chloroquine. Do not take any other prescription or over-the-counter medicines, including vitamins, minerals, and herbal products, without first talking to your doctor.
Aralen Hydrochloride, Aralen Phosphate, and chloroquine
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04